NCT06639555

Initial Clinical and CBCT Outcomes of Enamel Matrix Derivative-Based Regenerative Therapy in Vertical Bone Defects

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 48 (actual)
• Sponsor: Tsvetalina Gerova-Vatsova · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

Study of the effectiveness of the application of regenerative therapy with autogenous, platelet-rich plasma in vertical defects Investigation of the effectiveness of the application of regenerative therapy with enamel matrix derivatives in vertical bone defects Study of the effectiveness of the application of guided tissue regeneration in vertical bone defects with Barrier membrane and Barrier membrane and autogenous platelet-rich plasma

Conditions

• Vertical Alveolar Bone Loss

Interventions

Type	Name	Description
PROCEDURE	PRP( platelet rich plasma)	regenerative therapy with PRP for vertical bone defects
PROCEDURE	EMD (Enamel Matrix Derivative)	regenerative therapy with EMD for vertical bone defects
PROCEDURE	Guided Tissue Regeneration (barrier membrane)	guided tissue regeneration with barrier membrane alone for vertical bone defects
PROCEDURE	Guided Tissue Regeneration(barrier membrane and PRP)	guided tissue regeneration with barrier membrane and PRP for vertical bone defects

Timeline

• Start date: 2022-06-24
• Primary completion: 2023-02-15
• Completion: 2023-08-15
• First posted: 2024-10-15
• Last updated: 2024-10-15

Locations

1 site across 1 country: Bulgaria